-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Claudia Ibarra Sells 2,449 Shares of DermTech, Inc. (NASDAQ:DMTK) Stock
Claudia Ibarra Sells 2,449 Shares of DermTech, Inc. (NASDAQ:DMTK) Stock
DermTech, Inc. (NASDAQ:DMTK – Get Rating) COO Claudia Ibarra sold 2,449 shares of the stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $5.65, for a total value of $13,836.85. Following the completion of the transaction, the chief operating officer now directly owns 161,105 shares in the company, valued at $910,243.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Claudia Ibarra also recently made the following trade(s):
Get DermTech alerts:- On Tuesday, September 6th, Claudia Ibarra sold 133 shares of DermTech stock. The shares were sold at an average price of $5.43, for a total value of $722.19.
- On Monday, June 13th, Claudia Ibarra sold 345 shares of DermTech stock. The shares were sold at an average price of $4.81, for a total value of $1,659.45.
DermTech Trading Down 1.5 %
Shares of DMTK stock opened at $5.97 on Friday. The company has a market capitalization of $179.34 million, a P/E ratio of -1.68 and a beta of 1.49. The business's 50 day moving average is $6.57 and its two-hundred day moving average is $8.59. DermTech, Inc. has a 12-month low of $4.18 and a 12-month high of $36.80.
Analysts Set New Price Targets
A number of research analysts have recently weighed in on DMTK shares. BTIG Research cut their price objective on DermTech from $19.00 to $15.00 and set a "buy" rating on the stock in a report on Monday, August 15th. Lake Street Capital lowered their target price on DermTech from $34.00 to $14.00 in a research note on Tuesday, August 9th. Oppenheimer lowered their target price on DermTech from $48.00 to $23.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 17th. Finally, Craig Hallum lowered their target price on DermTech from $37.00 to $18.00 in a research note on Tuesday, August 9th.Hedge Funds Weigh In On DermTech
Hedge funds have recently bought and sold shares of the business. Wolverine Asset Management LLC purchased a new position in DermTech during the fourth quarter worth approximately $43,000. Amalgamated Bank purchased a new position in shares of DermTech in the first quarter valued at approximately $58,000. Financial Management Professionals Inc. purchased a new position in shares of DermTech in the second quarter valued at approximately $26,000. Ensign Peak Advisors Inc purchased a new position in shares of DermTech in the fourth quarter valued at approximately $82,000. Finally, Integrated Advisors Network LLC purchased a new position in shares of DermTech in the first quarter valued at approximately $147,000. Hedge funds and other institutional investors own 58.74% of the company's stock.
About DermTech
(Get Rating)
DermTech, Inc, a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers DermTech Melanoma Test (DMT), a gene expression test that enhances early detection of genomic atypia and helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions.
Featured Articles
- Get a free copy of the StockNews.com research report on DermTech (DMTK)
- MarketBeat: Week in Review 9/5 – 9/9
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
- The Auto Market Is Slowly Recovering, These Stocks May Outperform
- Is DocuSign On The Verge Of A Major Reversal?
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
Receive News & Ratings for DermTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DermTech and related companies with MarketBeat.com's FREE daily email newsletter.
DermTech, Inc. (NASDAQ:DMTK – Get Rating) COO Claudia Ibarra sold 2,449 shares of the stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $5.65, for a total value of $13,836.85. Following the completion of the transaction, the chief operating officer now directly owns 161,105 shares in the company, valued at $910,243.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
納斯達克首席運營官克勞迪婭·伊巴拉在日期為9月8日(星期四)的交易中出售了2,449股該公司股票。這些股票的平均價格為5.65美元,總價值為13,836.85美元。交易完成後,首席運營官現在直接擁有該公司161,105股,價值910,243.25美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過美國證券交易委員會網站訪問。
Claudia Ibarra also recently made the following trade(s):
克勞迪婭·伊巴拉最近還進行了以下交易:
- On Tuesday, September 6th, Claudia Ibarra sold 133 shares of DermTech stock. The shares were sold at an average price of $5.43, for a total value of $722.19.
- On Monday, June 13th, Claudia Ibarra sold 345 shares of DermTech stock. The shares were sold at an average price of $4.81, for a total value of $1,659.45.
- 9月6日,星期二,克勞迪婭·伊巴拉出售了133股德美科技的股票。這些股票的平均售價為5.43美元,總價值為722.19美元。
- 6月13日,星期一,克勞迪婭·伊巴拉出售了345股德美科技的股票。這些股票的平均價格為4.81美元,總價值為1,659.45美元。
DermTech Trading Down 1.5 %
DermTech股價下跌1.5%
Shares of DMTK stock opened at $5.97 on Friday. The company has a market capitalization of $179.34 million, a P/E ratio of -1.68 and a beta of 1.49. The business's 50 day moving average is $6.57 and its two-hundred day moving average is $8.59. DermTech, Inc. has a 12-month low of $4.18 and a 12-month high of $36.80.
上週五,DMTK股票開盤報5.97美元。該公司市值為1.7934億美元,市盈率為-1.68,貝塔係數為1.49。該業務的50日移動均線切入位在6.57美元,200日移動均線切入位在8.59美元。DermTech,Inc.的12個月低點為4.18美元,12個月高位為36.80美元。
Analysts Set New Price Targets
分析師設定新的價格目標
Hedge Funds Weigh In On DermTech
對衝基金對DermTech的看法
Hedge funds have recently bought and sold shares of the business. Wolverine Asset Management LLC purchased a new position in DermTech during the fourth quarter worth approximately $43,000. Amalgamated Bank purchased a new position in shares of DermTech in the first quarter valued at approximately $58,000. Financial Management Professionals Inc. purchased a new position in shares of DermTech in the second quarter valued at approximately $26,000. Ensign Peak Advisors Inc purchased a new position in shares of DermTech in the fourth quarter valued at approximately $82,000. Finally, Integrated Advisors Network LLC purchased a new position in shares of DermTech in the first quarter valued at approximately $147,000. Hedge funds and other institutional investors own 58.74% of the company's stock.
對衝基金最近買賣了該公司的股票。金剛狼資產管理有限責任公司在第四季度購買了DermTech的一個新頭寸,價值約4.3萬美元。合併銀行在第一季度購買了DermTech的新頭寸,價值約58,000美元。金融管理專業人士公司在第二季度購買了價值約2.6萬美元的DermTech股票的新頭寸。Ensign Peak Advisors Inc.在第四季度購買了DermTech的新頭寸,價值約82,000美元。最後,集成顧問網絡有限責任公司在第一季度購買了DermTech的新頭寸,價值約147,000美元。對衝基金和其他機構投資者持有該公司58.74%的股票。
About DermTech
關於德美科技
(Get Rating)
(獲取評級)
DermTech, Inc, a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers DermTech Melanoma Test (DMT), a gene expression test that enhances early detection of genomic atypia and helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions.
分子診斷公司DermTech,Inc.開發和銷售新的非侵入性基因組測試,以診斷美國的皮膚癌、炎症性疾病和衰老相關疾病。它提供DermTech黑色素瘤測試(DMT),這是一種基因表達測試,可增強對基因組非典型性的早期檢測,並有助於排除黑色素瘤和對非典型色素病變進行手術活檢的必要性。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on DermTech (DMTK)
- MarketBeat: Week in Review 9/5 – 9/9
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
- The Auto Market Is Slowly Recovering, These Stocks May Outperform
- Is DocuSign On The Verge Of A Major Reversal?
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
- 免費獲取StockNews.com關於DermTech的研究報告(DMTK)
- MarketBeat:回顧一週9/5-9/9
- 為網絡安全股創紀錄的季度做準備
- 汽車市場正在緩慢復甦,這些股票可能表現優異
- DocuSign是否即將發生重大逆轉?
- 石油和天然氣股票:投資可再生能源的安全途徑
Receive News & Ratings for DermTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DermTech and related companies with MarketBeat.com's FREE daily email newsletter.
接受DermTech Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對DermTech和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧